Communiqués Attana AB

Actions

ATANA

SE0010547273

Cours en clôture NORDIC GROWTH MARKET Autres places de cotation 00:00:00 05/07/2024			Varia. 5j.	Varia. 1 janv.
0,074 ^SEK	-7,50 %		-9,76 %	-25,25 %

02/05	Attana AB publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
30/04	BioInvent annonce l'évaluation de la technologie d'Attana	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

BioInvent evaluating Attana Technology	30/04	AQ
Attana enters the third year of a five-year service and support contract with a leading health institute in the US	25/04	AQ
New paper using Attana tecnology to understand how viruses enter human cells	01/04	AQ
One of US leading health institutes has placed an order for an upgrade of an existing instrument, valued at $150k	05/03	AQ
New paper using Attana Technology to study structures on surface in Ion Liquids demonstrating the effect of surface charges on interaction properties.	13/02	AQ
New publication using Attana technology towards environmentally friendly and financially viable methods to create functional materials	23/01	AQ
New article using Attana's technology from National University of Singapore: Immunity differences in vaccinated individuals according to age, gender, lifestyle and other diseases	20/12	AQ
Biosensors to characterize immune response to bacterial diseases	18/12	AQ
Attana and Linnaeus University have published the first part of the science behind immunity profiles	05/12	AQ
Breakthrough order with new customer in the USA	04/12	AQ
Strengthened collaboration with European biotech customer who extends their service and support agreement for another 12 months.	23/11	AQ
A new publication using Attana Technology from National University of Singapore examining the neutralization capacity of human IgG antibodies agsinst different mutations of the SARS-CoV-2	20/11	AQ
Robust QCM-Based Sensing and Assay Formats in Commercialized Systems	15/11	AQ
Dear shareholders and valuable followers,	04/10/23	AQ
New publication that shows the strength of Attana's offering in diagnostics, here applied in veterinary medicine.	26/09/23	AQ
New publication from National University of Singapore using Attana Technology to study Immune Response from Tuberculosis Exposed Healthy Individuals	06/09/23	AQ
The Swedish Knowledge-Foundation has granted SEK 12 million to a project concerning individual immunity profiles for diagnostics and medical development based on Attana's QCM technology.	28/08/23	AQ
Education in advanced Attana cell-based assays and practical hands-on training in maintenance.	30/05/23	AQ
Attana prolongs service and support contract with European client	23/05/23	AQ
Attanas immunity profiles depicted in the Life Science section of yesterday's Dagens Nyheter	23/05/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Attana AB

Actions

ATANA

SE0010547273

Communiqués

Filtres